Cargando…
Early antitumor activity of oral Langerhans cells is compromised by a carcinogen
Early diagnosis of oral squamous cell carcinoma (OSCC) remains an unmet clinical need. Therefore, elucidating the initial events of OSCC preceding tumor development could benefit OSCC prognosis. Here, we define the Langerhans cells (LCs) of the tongue and demonstrate that LCs protect the epithelium...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784117/ https://www.ncbi.nlm.nih.gov/pubmed/35012988 http://dx.doi.org/10.1073/pnas.2118424119 |
_version_ | 1784638664160051200 |
---|---|
author | Saba, Yasmin Aizenbud, Itay Matanes, Daniela Koren, Noam Barel, Or Zubeidat, Khalid Capucha, Tal David, Eyal Eli-Berchoer, Luba Stoitzner, Patrizia Wilensky, Asaf Amit, Ido Czerninski, Rakefet Yona, Simon Hovav, Avi-Hai |
author_facet | Saba, Yasmin Aizenbud, Itay Matanes, Daniela Koren, Noam Barel, Or Zubeidat, Khalid Capucha, Tal David, Eyal Eli-Berchoer, Luba Stoitzner, Patrizia Wilensky, Asaf Amit, Ido Czerninski, Rakefet Yona, Simon Hovav, Avi-Hai |
author_sort | Saba, Yasmin |
collection | PubMed |
description | Early diagnosis of oral squamous cell carcinoma (OSCC) remains an unmet clinical need. Therefore, elucidating the initial events of OSCC preceding tumor development could benefit OSCC prognosis. Here, we define the Langerhans cells (LCs) of the tongue and demonstrate that LCs protect the epithelium from carcinogen-induced OSCC by rapidly priming αβT cells capable of eliminating γH2AX(+) epithelial cells, whereas γδT and natural killer cells are dispensable. The carcinogen, however, dysregulates the epithelial resident mononuclear phagocytes, reducing LC frequencies, while dendritic cells (DCs), macrophages, and plasmacytoid DCs (pDCs) populate the epithelium. Single-cell RNA-sequencing analysis indicates that these newly differentiated cells display an immunosuppressive phenotype accompanied by an expansion of T regulatory (Treg) cells. Accumulation of the Treg cells was regulated, in part, by pDCs and precedes the formation of visible tumors. This suggests LCs play an early protective role during OSCC, yet the capacity of the carcinogen to dysregulate the differentiation of mononuclear phagocytes facilitates oral carcinogenesis. |
format | Online Article Text |
id | pubmed-8784117 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | National Academy of Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-87841172022-07-10 Early antitumor activity of oral Langerhans cells is compromised by a carcinogen Saba, Yasmin Aizenbud, Itay Matanes, Daniela Koren, Noam Barel, Or Zubeidat, Khalid Capucha, Tal David, Eyal Eli-Berchoer, Luba Stoitzner, Patrizia Wilensky, Asaf Amit, Ido Czerninski, Rakefet Yona, Simon Hovav, Avi-Hai Proc Natl Acad Sci U S A Biological Sciences Early diagnosis of oral squamous cell carcinoma (OSCC) remains an unmet clinical need. Therefore, elucidating the initial events of OSCC preceding tumor development could benefit OSCC prognosis. Here, we define the Langerhans cells (LCs) of the tongue and demonstrate that LCs protect the epithelium from carcinogen-induced OSCC by rapidly priming αβT cells capable of eliminating γH2AX(+) epithelial cells, whereas γδT and natural killer cells are dispensable. The carcinogen, however, dysregulates the epithelial resident mononuclear phagocytes, reducing LC frequencies, while dendritic cells (DCs), macrophages, and plasmacytoid DCs (pDCs) populate the epithelium. Single-cell RNA-sequencing analysis indicates that these newly differentiated cells display an immunosuppressive phenotype accompanied by an expansion of T regulatory (Treg) cells. Accumulation of the Treg cells was regulated, in part, by pDCs and precedes the formation of visible tumors. This suggests LCs play an early protective role during OSCC, yet the capacity of the carcinogen to dysregulate the differentiation of mononuclear phagocytes facilitates oral carcinogenesis. National Academy of Sciences 2022-01-10 2022-01-18 /pmc/articles/PMC8784117/ /pubmed/35012988 http://dx.doi.org/10.1073/pnas.2118424119 Text en Copyright © 2022 the Author(s). Published by PNAS. https://creativecommons.org/licenses/by-nc-nd/4.0/This article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Biological Sciences Saba, Yasmin Aizenbud, Itay Matanes, Daniela Koren, Noam Barel, Or Zubeidat, Khalid Capucha, Tal David, Eyal Eli-Berchoer, Luba Stoitzner, Patrizia Wilensky, Asaf Amit, Ido Czerninski, Rakefet Yona, Simon Hovav, Avi-Hai Early antitumor activity of oral Langerhans cells is compromised by a carcinogen |
title | Early antitumor activity of oral Langerhans cells is compromised by a carcinogen |
title_full | Early antitumor activity of oral Langerhans cells is compromised by a carcinogen |
title_fullStr | Early antitumor activity of oral Langerhans cells is compromised by a carcinogen |
title_full_unstemmed | Early antitumor activity of oral Langerhans cells is compromised by a carcinogen |
title_short | Early antitumor activity of oral Langerhans cells is compromised by a carcinogen |
title_sort | early antitumor activity of oral langerhans cells is compromised by a carcinogen |
topic | Biological Sciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784117/ https://www.ncbi.nlm.nih.gov/pubmed/35012988 http://dx.doi.org/10.1073/pnas.2118424119 |
work_keys_str_mv | AT sabayasmin earlyantitumoractivityoforallangerhanscellsiscompromisedbyacarcinogen AT aizenbuditay earlyantitumoractivityoforallangerhanscellsiscompromisedbyacarcinogen AT matanesdaniela earlyantitumoractivityoforallangerhanscellsiscompromisedbyacarcinogen AT korennoam earlyantitumoractivityoforallangerhanscellsiscompromisedbyacarcinogen AT barelor earlyantitumoractivityoforallangerhanscellsiscompromisedbyacarcinogen AT zubeidatkhalid earlyantitumoractivityoforallangerhanscellsiscompromisedbyacarcinogen AT capuchatal earlyantitumoractivityoforallangerhanscellsiscompromisedbyacarcinogen AT davideyal earlyantitumoractivityoforallangerhanscellsiscompromisedbyacarcinogen AT eliberchoerluba earlyantitumoractivityoforallangerhanscellsiscompromisedbyacarcinogen AT stoitznerpatrizia earlyantitumoractivityoforallangerhanscellsiscompromisedbyacarcinogen AT wilenskyasaf earlyantitumoractivityoforallangerhanscellsiscompromisedbyacarcinogen AT amitido earlyantitumoractivityoforallangerhanscellsiscompromisedbyacarcinogen AT czerninskirakefet earlyantitumoractivityoforallangerhanscellsiscompromisedbyacarcinogen AT yonasimon earlyantitumoractivityoforallangerhanscellsiscompromisedbyacarcinogen AT hovavavihai earlyantitumoractivityoforallangerhanscellsiscompromisedbyacarcinogen |